Generex Biotechnology Corporation
GNBT · OTC
7/31/2020 | 7/31/2019 | 7/31/2018 | 7/31/2017 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $1 | $3 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $1 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $1 | $1 | $1 | $3 |
| Property Plant & Equip (Net) | $0 | $1 | $0 | $0 |
| Goodwill | $34 | $38 | $0 | $0 |
| Intangibles | $9 | $10 | $3 | $3 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $2 | $4 |
| Total NC Assets | $44 | $49 | $5 | $7 |
| Other Assets | $0 | -$17 | $0 | $0 |
| Total Assets | $45 | $33 | $7 | $10 |
| Liabilities | – | – | – | – |
| Payables | $24 | $19 | $11 | $10 |
| Short-Term Debt | $11 | $8 | $14 | $14 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | -$25 | -$24 |
| Other Curr. Liab. | $7 | $2 | $25 | $24 |
| Total Curr. Liab. | $41 | $29 | $25 | $24 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | -$2 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $2 | $1,502 | $0 | $0 |
| Other NC Liab. | $15 | -$1,489 | $25 | $66 |
| Total NC Liab. | $16 | $13 | $25 | $66 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $57 | $42 | $50 | $90 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$452 | -$419 | -$409 | -$446 |
| AOCI | $1 | $1 | $1 | $1 |
| Other Equity | $430 | $409 | $371 | $371 |
| Total Equity | -$21 | -$9 | -$38 | -$74 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $4 | $0 | -$6 | -$6 |
| Total Liab. & Tot. Equity | $36 | $33 | $7 | $10 |
| Net Debt | $11 | $8 | $13 | $11 |